The jejunum, which is the middle section of the small intestine, plays a critical role in drug delivery and absorption for several reasons:
- Absorption Surface Area: The jejunum has a highly folded surface with villi and microvilli, which significantly increases the surface area available for absorption. This feature enhances the capacity of the jejunum to absorb drugs efficiently.
- Permeability: The epithelial cells of the jejunum possess properties that facilitate the absorption of various drug formulations, including small molecules, peptides, and larger macromolecules. The jejunum exhibits higher permeability compared to the stomach or duodenum.
- pH Environment: The jejunum maintains a relatively neutral to slightly alkaline pH, which can be favorable for the dissolution and absorption of many drugs that are poorly soluble in acidic conditions.
- Absorption Mechanisms: The jejunum employs several mechanisms for drug absorption, including passive diffusion, facilitated diffusion, active transport, and endocytosis, allowing for a wide variety of compounds to be absorbed.
- Less First-pass Metabolism: Drugs absorbed in the jejunum may experience less first-pass metabolism compared to those absorbed in the stomach, which can lead to better bioavailability. The jejunum's position ensures that many drugs are passed to the liver indirectly through the portal vein, thus minimizing degradation before reaching systemic circulation.
- Rapid Transit: The motility of the jejunum allows for relatively rapid transit times, which can affect the time drugs take to reach systemic circulation and their overall efficacy.
- Formulation Considerations: Understanding the characteristics of the jejunum is crucial for formulating oral drug delivery systems (like tablets or capsules) that optimize drug release and absorption in this segment of the intestine.
Overall, the jejunum's anatomical and physiological features make it a key site for the absorption of orally administered drugs, influencing pharmacokinetics and therapeutic effectiveness.
When designing drug formulations, it is essential to consider these factors to enhance drug delivery and patient outcomes.
# # #
Pion Inc. has a long history of helping drug formulators in their drug development efforts. Our in vitro characterization technologies are designed to help scientists like you improve the oral absorption of drugs. By providing deep insights into the dissolution and absorption profiles of your formulations, we can help you refine your approach and enhance the effectiveness of your drug products.
We’ve assembled a product line of novel instruments to assist researchers in the drug development process, including our Rainbow Dynamic Dissolution Monitoring System which uses in-situ, fiber optic UV-vis probes to monitor multiple dissolution and flux (permeability) experiments at the same time. Our flux systems use a biomimetic membrane to simulate jejunum permeability.
We have also developed our new Predictor software that allows users to convert in vitro flux data to predictions of in vivo oral absorption and percent fraction drug absorbed (Fa%). Predictor assigns an estimation of the rate-limiting step to absorption of the API and defines whether the compound is subject to a permeability, dissolution, or solubility-permeability limitations.
At Pion Inc., we help drug formulators develop drugs with high efficacy more quickly. We help you understand the interplay between drug solubility, liberation/dissolution, and permeability/absorption.
Contact us today to learn more.
